AEON BIOPHARMA
Live / Applied — First extension granted (statement of use) (as of 11 Dec 2025)
What this means for you
Not registered yet, but its 23 Sept 2019 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88626873
- Mark type
- Stylized text
- Filed
- 23 Sept 2019
- Published for opposition
- 06 May 2025
- Attorney of record
- Alexis Crawford Douglas
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological conditions; Pharmaceutical preparations for the treatment of gastrointestinal conditions; Pharmaceutical preparations for the treatment of neurologic and psychiatric disorders; botulinum toxins for therapeutic use
Owner
- AEON Biopharma, Inc., Irvine, CA, US
- AEON Biopharma, Inc., Irvine, CA, US
Prosecution history
- 12 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2025 — SOU EXTENSION 1 GRANTED
- 11 Dec 2025 — SOU EXTENSION 1 FILED
- 11 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jan 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 27 Feb 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 09 Feb 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 31 Jul 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 31 Jul 2023 — LETTER OF SUSPENSION E-MAILED
- 31 Jul 2023 — SUSPENSION LETTER WRITTEN